CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 52,071	$ 3,891
Research and development incentive receivable	73	185
Prepaid expenses and other current assets	130	165
Total current assets	52,274	4,241
Property and equipment, net	65	124
Right of use asset, net	528	1,026
Deferred tax assets	179	127
Deferred costs	345	831
Deposits	980	1,099
Total assets	54,371	7,448
Current liabilities:
Accounts payable	2,717	4,571
Accrued expenses	2,747	3,441
Deferred revenue - current portion	1,500
Lease liability - current portion	408	474
Total current liabilities	7,372	8,486
Non current liabilities:
Restricted stock liability	204	159
Lease liability, net of current portion	144	552
Total liabilities	7,720	9,197
Stockholders' equity (deficiency):
Common stock, $0.001 par value; 240,000,000 shares authorized; 59,657,742 and 24,194,877 shares issued and outstanding as of December 31, 2020 and 2019, respectively	60	24
Additional paid-in capital	270,155	193,319
Accumulated other comprehensive income (loss)	(579)	76
Accumulated deficit	(222,985)	(195,168)
Total stockholders' equity (deficiency)	46,651	(1,749)
Total liabilities and stockholders' equity (deficiency)	$ 54,371	$ 7,448